Medical Compression Systems (MCS) is a leader in innovative, non-invasive solutions for the prevention of venous thromboembolism (VTE). The company is the first and currently the only to offer the healthcare market a new class of proven Continuous Enhanced Circulation Therapy in combination with MCS’s patented Synchronized Flow Technology (C.E.C.T.® + S.F.T.) devices, which can minimize the need for pharmaceutical therapy as the current standard of care.
The company’s products have US FDA clearance and are CE approved; its products are protected by numerous patents.
Founded in 1997, MCS Medical Compression Systems (Ltd.), is an Israeli public company, traded on the Tel Aviv Stock Exchange (TASE: MDCL). MCS Inc., the company’s subsidiary, is located in the USA.